Funder: National Institutes of Health

Due Dates: May 6, 2025 (Letter of Intent) | June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision) | October 5, 2026 (New) | November 5, 2026 (Renewal/Resubmission/Revision) | February 5, 2027 (New) | March 5, 2027 (Renewal/Resubmission/Revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/Resubmission/Revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $500,000 direct costs per year, for a maximum project period of 5 years.

Summary: Supports investigator-initiated studies on the biological mechanisms by which bariatric surgery impacts cancer risk, emphasizing mechanistic over short-term metabolic outcomes.

Key Information: Clinical trial proposals are allowed but must include a bariatric surgeon as a key investigator; epidemiologic-only studies are not responsive.